MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

EEG guided neurofeedback boosts effects of motor cortex neuromodulation of rTMS in Parkinson´s Disease Patients

J. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, E. Sanz, M. Gil, E. Rodriguez (Madrid, Spain)

Meeting: 2019 International Congress

Abstract Number: 2124

Keywords: Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Pharmacological Interventions

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To compare the clinical and neurophysiological effects of EEG guided Neurofeedback (NFB) vs 10Hz rTMS vs combined therapy (NFB+rTMS) in motor cortex of non-demented HY I-III PD patients

Background: rTMS has been shown in several studies to produce significant reduction in PD motor scores and increase of cortical silent period (CSP) when administered at high frequencies in M1[1,2,3], but its effects have not been long lasting. To our knowledge there are not studies comparing its effects with NFB nor testing a combined protocol of both techniques

Method: 30 non demented PD  divided in 3  groups (no differences in sex (χ2(2)=0.2; p=0.89), age (F(2,31)= 0.07; p=0.932) or education (F(2,31)= 0,73; p=0.491),). UPDRS III 15,94±7,03 (SD), 598±315mg LED/day. rTMS group received 8 daily bilateral sessions 2000 pulses 10Hz 80%RMT. 5 min interval between hemispheres. NFB group received 8 30 minute sessions of visual feedback using 3D virtual reality oculus® googles (goal: increase in average alpha and beta frequency in 6 central EEG derivations). Combined therapy group received 8 sessions of rTMS followed by NFB protocol the same day. UPDRSIII and CSP were measured pre- intervention (A), after the completion of the protocol(B) and 15 days after completing the protocol (C).

Results: There was a reduction of UPDRS III scores in the combined group (F (2.18) = 15.38, p <0.001) between measurement A and B (μA-μB = -4.90, p = 0.001 ), which was maintained in C (μA-μC = -4.40, p = 0.014). In the rTMS group there was a reduction of the UPDRS III scores (F (2.20) = 2.44, p = 0.112) between measurement A and C (μA-μC = -4.63, p = 0.038). The NFB group did not register any improvement. CSP increased in both hemispheres significantly only in the combined group between A and B. Right hemisphere (F (2,18) = 2,393; p = 0.079); (μA-μB = -0,039; p = 0.023 ). Left hemisphere (F (2.18) = 5.53, p = 0.013) (μA-μB = -0, 039, p = 0.034).

Conclusion: Motor and neurophysiological effects of NFB alone are not comparable to rTMS, but it seems that priming the NFB training with rTMS M1 pre activation results in long lasting significant motor improvement in PD patients. This protocol shows promising effects of combining rTMS with a non-invasive and highly accessible technique that can prolong its effects having a real impact in treatment of motor symptoms of the disease.

References: 1 Lefaucheur, et al. (2004). “Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson’s disease”. Clinical Neurophysiology, 115(11), 2530-2541. 2 Maruo, et al. (2013). “High-Frequency Repetitive Transcranial Magnetic Stimulation over the Primary Foot Motor Area in Parkinson’s Disease”. Brain Stimulation, 6(6), 884-891. 3 Aftanas, et al (2018). “Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study”. Bulletin of Experi

To cite this abstract in AMA style:

J. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, E. Sanz, M. Gil, E. Rodriguez. EEG guided neurofeedback boosts effects of motor cortex neuromodulation of rTMS in Parkinson´s Disease Patients [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/eeg-guided-neurofeedback-boosts-effects-of-motor-cortex-neuromodulation-of-rtms-in-parkinsons-disease-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/eeg-guided-neurofeedback-boosts-effects-of-motor-cortex-neuromodulation-of-rtms-in-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley